Boston Scientific CORP Schedule 13G passive stakes

FMR LLC and Abigail P. Johnson have jointly filed a Schedule 13G, reporting beneficial ownership of 46,378,258.61 shares of Boston Scientific Corp. common stock, representing 3.1% of the class.

FMR LLC and Abigail P. Johnson have reported a combined beneficial ownership of 5.1% of Boston Scientific Corp.'s common stock as of March 31, 2026.

Vanguard Capital Management has reported a beneficial ownership of 7.47% in Boston Scientific Corp. common stock as of March 31, 2026.

The Vanguard Group reports 0% beneficial ownership in Boston Scientific Corp following an internal realignment, shifting reporting to subsidiaries.

FMR LLC and Abigail P. Johnson have disclosed a 7.5% beneficial ownership stake in Boston Scientific Corp, holding over 110 million shares.

BlackRock, Inc. has filed an amended Schedule 13G, reporting a 7.6% passive beneficial ownership stake in Boston Scientific Corp as of March 31, 2025.

FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting a passive beneficial ownership of 9.6% of Boston Scientific Corp.'s common stock as of December 29, 2023.